Indo Amines

₹130.5 0.7 | 0.5%

WEBSITE BSE:524648 NSE : INDO AMINES 10 May, 16:01

Market Cap ₹923 Cr.

Stock P/E 18.2

P/B 3.6

Current Price ₹130.5

Book Value ₹ 36

Face Value 5

52W High ₹184.8

Dividend Yield 0.38%

52W Low ₹ 88.6

Edit Ratio

Indo Amines Research see more...

Overview Inc. Year: 1992Industry: Chemicals

Indo Amines Ltd manufactures, develops, and materials chemical substances, speciality chemicals, performance chemical, perfumery chemicals, and API components international. The agency’s fine chemical compounds comprise aliphatic and aromatic amines, aliphatic and aromatic nitriles, halides, alcohols, cycloalkanols, cycloalkanones, acids and esters, advanced intermediates, amine hydrochlorides, ethanol amines, and other products. Its speciality chemical compounds encompass fatty acids, amides, amines, di-amines, tertiary amines, polyamines, amine ethoxylates, and ammonium quats. The organization’s overall performance chemicals contain anti-caking, anti-foaming, anti-static, anti-stripping, anti-bacterial/anti-slime, and floatation marketers, as well as granulating aids, defoamers, curing aids, bitumen emulsifiers, corrosion inhibitors, demulsifiers, and anti-bacterial products. Its products are utilized in pharma, agrochemicals, fertilizers, petrochemicals, perfumery chemical substances, road construction, pesticides, dyes and intermediates, water remedy chemical substances, oil field chemical substances, mining, paints, pigments, polymers, steel running and lubricants, components, fabric processing chemical compounds, cosmetics, domestic and personal care applications, and so forth. Indo Amines Ltd was established in 1992 and is based in Thane, India.

Indo Amines Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Indo Amines Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	184	212	214	258	241	211	235	244	253	194
Other Income	2	3	1	1	1	1	2	4	5	2
Total Income	186	215	215	259	242	212	237	248	258	196
Total Expenditure	173	195	202	239	225	190	204	222	233	174
Operating Profit	12	20	13	20	17	21	33	26	26	22
Interest	3	4	4	3	4	5	5	6	6	6
Depreciation	3	4	4	4	4	5	4	4	3	4
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	5	12	6	13	8	12	23	17	16	12
Provision for Tax	2	3	3	4	3	2	6	4	5	3
Profit After Tax	4	10	2	8	5	10	17	12	12	10
Adjustments	-0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	4	10	2	8	5	10	17	12	12	10
Adjusted Earnings Per Share	0.6	1.4	0.3	1.2	0.7	1.5	2.4	1.7	1.7	1.4

Indo Amines Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	200	221	234	253	286	355	528	479	541	786	945	926
Other Income	2	1	1	1	5	4	7	7	8	10	4	13
Total Income	202	221	235	253	291	360	535	485	549	796	949	939
Total Expenditure	185	202	212	222	250	315	473	437	479	734	858	833
Operating Profit	17	19	24	31	41	45	62	49	69	63	91	107
Interest	4	4	5	4	6	8	10	11	9	14	17	23
Depreciation	3	6	10	12	12	12	15	20	11	14	17	15
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	10	9	8	15	23	25	38	18	49	35	57	68
Provision for Tax	3	3	3	6	7	9	13	6	12	11	16	18
Profit After Tax	7	6	5	9	16	16	25	13	37	23	41	51
Adjustments	0	0	0	0	0	0	-0	-1	0	-0	-0	0
Profit After Adjustments	7	6	5	9	16	16	25	12	38	23	40	51
Adjusted Earnings Per Share	1.3	0.9	0.8	1.4	2.4	2.3	3.6	1.8	5.4	3.2	5.7	7.2

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	20%	25%	22%	17%
Operating Profit CAGR	44%	23%	15%	18%
PAT CAGR	78%	47%	21%	19%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	46%	29%	26%	34%
ROE Average	20%	20%	19%	19%
ROCE Average	17%	17%	17%	18%

Indo Amines Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	35	41	45	50	69	81	125	135	163	187	225
Minority's Interest	0	0	0	0	0	0	0	-1	-0	0	0
Borrowings	9	5	8	14	14	19	26	36	53	51	58
Other Non-Current Liabilities	2	2	1	-1	-1	1	1	1	-2	2	4
Total Current Liabilities	88	108	101	102	127	143	192	189	236	314	309
Total Liabilities	134	156	155	165	209	244	344	360	450	554	597
Fixed Assets	27	34	53	51	63	70	116	117	125	182	198
Other Non-Current Assets	13	15	3	1	44	15	20	31	61	32	27
Total Current Assets	94	106	99	112	102	159	209	211	265	340	373
Total Assets	134	156	155	165	209	244	344	360	450	554	597

Indo Amines Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	4	4	5	6	6	5	8	10	10	15	24
Cash Flow from Operating Activities	19	19	23	19	15	8	27	39	56	15	20
Cash Flow from Investing Activities	-14	-21	-14	-10	-23	-21	-43	-36	-50	-39	-30
Cash Flow from Financing Activities	-5	2	-9	-9	7	16	17	-3	-1	32	4
Net Cash Inflow / Outflow	1	0	1	0	-1	3	2	0	5	9	-5
Closing Cash & Cash Equivalent	4	5	6	6	5	8	10	10	15	24	18

Indo Amines Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	1.26	0.93	0.8	1.38	2.42	2.34	3.55	1.81	5.35	3.23	5.72
CEPS(Rs)	1.78	1.87	2.35	3.22	4.23	4.18	5.64	4.57	6.88	5.25	8.23
DPS(Rs)	0.5	0.25	0.25	0.5	0.5	0.5	0.5	0.5	0.55	0.5	0.5
Book NAV/Share(Rs)	6.38	6.52	6.81	7.59	10.37	11.91	17.47	18.88	22.83	26.32	31.68
Core EBITDA Margin(%)	6.24	7.29	8.63	10.57	11.16	10.01	8.89	6.93	9.19	4.78	6.57
EBIT Margin(%)	5.91	5.2	5.17	6.6	8.88	8.03	7.7	4.8	8.72	4.44	5.58
Pre Tax Margin(%)	4.13	3.6	3.09	5.16	7.08	6.08	6.12	3.02	7.34	3.16	4.28
PAT Margin (%)	2.83	2.3	2.02	3.19	5.02	3.85	4.06	2.11	5.61	2.11	3.08
Cash Profit Margin (%)	4	4.64	5.95	7.44	8.78	6.89	6.41	5.32	7.29	3.4	4.39
ROA(%)	5.35	3.97	3.38	5.68	8.63	6.88	8.58	3.64	9.26	4.59	7.1
ROE(%)	21.89	15.46	12.3	19.2	27.12	20.98	24.87	9.97	25.42	13.26	19.94
ROCE(%)	18.44	14.75	14.13	19.18	24.64	21.56	22.54	10.99	19.49	13.58	17.43
Receivable days	72.26	71.93	62.96	54.5	60.46	60.85	54.86	62.63	62.08	49.91	48.82
Inventory Days	36.09	34	36.07	34.48	33.99	38.47	34.69	44.32	46.36	35.19	35.56
Payable days	89.19	99.21	87.37	74.97	69.17	86.11	75.3	90.21	98.31	85.26	69.1
PER(x)	4.16	5.31	12.88	13.9	14.91	18.19	13.24	7.82	8.22	28.7	13.55
Price/Book(x)	0.82	0.75	1.51	2.53	3.48	3.57	2.69	0.75	1.93	3.52	2.45
Dividend Yield(%)	4.78	5.09	2.43	2.6	1.39	1.18	1.06	3.53	1.25	0.54	0.65
EV/Net Sales(x)	0.35	0.36	0.48	0.68	1.04	1.03	0.86	0.49	0.84	1.07	0.81
EV/Core EBITDA(x)	4.2	4.21	4.76	5.52	7.34	8.18	7.27	4.8	6.56	13.4	8.34
Net Sales Growth(%)	4.57	10.26	6.08	7.94	13.31	24.14	48.62	-9.34	12.91	45.42	20.22
EBIT Growth(%)	21.03	-6.56	3.34	39.57	51.85	13.86	47.18	-38.96	99.37	-16.7	52.67
PAT Growth(%)	63.64	-13.71	-8.81	73.22	77.54	-3.45	61.87	-49.22	192.49	-38.51	77.35
EPS Growth(%)	49.78	-26.33	-13.8	73.22	75.24	-3.45	52	-48.98	195.31	-39.69	77.21
Debt/Equity(x)	1.38	1.33	1.14	1.01	0.9	1.14	1.06	1.07	0.99	1.11	1.04
Current Ratio(x)	1.07	0.99	0.98	1.1	0.81	1.11	1.09	1.12	1.12	1.08	1.21
Quick Ratio(x)	0.82	0.76	0.71	0.84	0.54	0.75	0.74	0.69	0.75	0.69	0.77
Interest Cover(x)	3.32	3.26	2.49	4.59	4.93	4.12	4.87	2.69	6.31	3.47	4.29
Total Debt/Mcap(x)	1.68	1.76	0.76	0.4	0.26	0.32	0.42	1.51	0.51	0.32	0.42

Indo Amines Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	69.32	69.33	69.33	69.03	68.35	67.4	67.37	66.87	66.76	66.76
FII	0	0	0.01	0.06	0.17	0.06	0	0	0.1	0.05
DII	0	0	0	0	0	0	0	0	0	0
Public	30.68	30.67	30.66	30.91	31.48	32.55	32.63	33.13	33.15	33.19
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	2.45	4.9	4.9	4.88	4.83	4.76	4.76	4.73	4.72	4.72
FII	0	0	0	0	0.01	0	0	0	0.01	0
DII	0	0	0	0	0	0	0	0	0	0
Public	1.08	2.17	2.17	2.19	2.23	2.3	2.31	2.34	2.34	2.35
Others	0	0	0	0	0	0	0	0	0	0
Total	3.53	7.07	7.07	7.07	7.07	7.07	7.07	7.07	7.07	7.07

Pros

Debtor days have improved from 85.26 to 69.1days.

Cons

Stock is trading at 3.6 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.